Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Longitudinal Study of Neurological Disease Trajectory in Children Living With Late-Infantile or Juvenile Onset of GM1 or GM2 Gangliosidosis

NCT05109793 is registered in ClinicalTrials.gov with Azafaros B.V. as lead sponsor.

NCT NCT05109793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05109793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Longitudinal Study of Neurological Disease Trajectory in Children Living With Late-Infantile or Juvenile Onset of GM1 or GM2 Gangliosidosis
Lead sponsor
Azafaros B.V.
Phase
Observational
Overall status
Completed
Start date
February 22, 2022
Completion date
September 16, 2025
Enrollment
31 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

gm1 gangliosidosis, sandhoff disease, tay-sachs disease